Isolated peptide or polypeptide of the extracellular portion of the human interferon receptor (IFN-R).
US6787634B2 · kind B2 · utility
22Cited by
10References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 1999 |
| Grant date | Sep 7, 2004 |
| Priority date | — |
| Expiry date | Feb 3, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A monoclonal antibody is provided which is directed against the human interferon type I receptor (IFN-R), which recognizes the extracellular domain of the human IFN-R and which has neutralizing capacity against the biological properties of human type I-IFN. Diagnostic and therapeutic applications for the monoclonal antibody also are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.